CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 85  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0602
LYS 10.0465
GLU 20.0367
LEU 30.0189
ARG 40.0308
CYS 50.0182
GLN 60.0381
CYS 70.0328
ILE 80.0113
LYS 90.0478
THR 100.0129
TYR 110.0149
SER 120.0313
LYS 130.0452
PRO 140.0233
PHE 150.0082
HIS 160.0034
PRO 170.0046
LYS 180.0100
PHE 190.0172
ILE 200.0047
LYS 210.0120
GLU 220.0206
LEU 230.0222
ARG 240.0199
VAL 250.0288
ILE 260.0264
GLU 270.0081
SER 280.0093
GLY 290.0352
PRO 300.0352
HIS 310.0135
CYS 320.0337
ALA 330.0602
ASN 340.0261
THR 350.0183
GLU 360.0149
ILE 370.0124
ILE 380.0201
VAL 390.0088
LYS 400.0082
LEU 410.0146
SER 420.0162
ASP 430.0175
GLY 440.0232
ARG 450.0220
GLU 460.0223
LEU 470.0159
CYS 480.0180
LEU 490.0077
ASP 500.0108
PRO 510.0157
LYS 520.0191
GLU 530.0172
ASN 540.0215
TRP 550.0139
VAL 560.0067
GLN 570.0153
ARG 580.0241
VAL 590.0152
VAL 600.0137
GLU 610.0111
LYS 620.0086
PHE 630.0048
LEU 640.0072
LYS 650.0161
ARG 660.0083
ALA 670.0138
GLU 680.0169
ASN 690.0118

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.